Related Experiment Video
Updated: Mar 31, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Cross-Population Validation of the Pediatric CKD Risk-Prediction Tool
Peong Gang Park1,2, Jayoun Kim3, Naye Choi4
1Division of Pediatric Nephrology, Severance Children's Hospital, Seoul, South Korea.
Insights
This study validated a kidney replacement therapy (KRT) risk calculator for pediatric chronic kidney disease (CKD) in East Asian children. The calculator showed strong predictive ability, especially when incorporating estimated GFR slope, aiding clinical decisions.
Area of Science:
- Pediatric Nephrology
- Biostatistics
- Clinical Epidemiology
Background:
- Chronic kidney disease (CKD) affects children globally, necessitating accurate prognostication tools.
- Predicting kidney replacement therapy (KRT) is crucial for managing pediatric CKD.
- External validation of existing risk calculators in diverse populations is essential.
Purpose of the Study:
- To externally validate the performance of a KRT risk prediction calculator for pediatric CKD.
- To assess the calculator's utility in an ethnically distinct East Asian cohort.
- To identify potential improvements for enhanced predictive accuracy.
Main Methods:
- Utilized the KoreaN Cohort Study on Outcomes in Pediatric CKD (KNOW-Ped CKD) cohort for validation.
- Employed six parametric survival models from the generalized gamma family, stratified by GFR change or cross-sectional data.
- Addressed missing data using multiple imputations and evaluated performance via goodness-of-fit, discrimination, calibration, and predictive ability.
Main Results:
- Included 533 children with a median follow-up of 4.8 years; 32.1% initiated KRT.
- Validated models demonstrated excellent discrimination (C-statistic: 0.911-0.972) and calibration slopes > 0.9.
- Models incorporating estimated GFR slope showed the best alignment with observed KRT initiation risks, despite some miscalibration noted by the goodness-of-fit test.
Conclusions:
- The KRT risk prediction calculator shows potential for improving prognostication in pediatric CKD.
- Enhanced models, particularly those using eGFR slope, offer improved accuracy for clinical decision-making.
- External validation in diverse populations confirms the calculator's applicability and highlights areas for refinement.
Introduction:
This study aimed to externally validate the performance of the kidney replacement therapy (KRT) risk prediction calculator for chronic kidney disease (CKD) in children in an ethnically distinct East Asian population.
Methods:
We externally validated the KRT risk prediction calculator for CKD in children using data from the KoreaN Cohort Study on Outcomes in Pediatric CKD (KNOW-Ped CKD) cohort. Six parametric survival models from the generalized gamma family were tested, stratified into 2 groups as follows: change in glomerular filtration rate (GFR)-based (group 1) and cross-sectional (group 2). Missing data (≤ 7.9%) were addressed via multiple imputations using chained equations. Outcomes were timed to KRT initiation. The model performance was evaluated based on goodness-of-fit, discrimination ability, calibration, and predictive ability.
Results:
Overall, 533 children were included in the validation cohort. The median age and baseline estimated GFR (eGFR) were 10.8 years (interquartile range [IQR]: 5.3-14.5) and 57.6 ml/min per 1.73 m2 (IQR: 34.8-81.4), respectively. Over a median follow-up of 4.8 years (IQR: 2.0-8.9), KRT was initiated in 171 participants (32.1%). Models in group 1 (n = 433) and 2 (n = 533) demonstrated excellent discrimination ability (C-statistic: 0.911-0.972). The calibration slopes exceeded 0.9 across all models, though the Greenwood-Nam-D'Agostino goodness-of-fit test indicated a miscalibration (P < 0.001). Enriched models incorporating the eGFR slope showed the closest alignment with the observed risks.
Conclusion:
These findings underscore the potential utility of the calculator in improving prognostication and clinical decision-making in pediatric CKD.
More Related Videos
Related Concept Videos
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

